« Back to Record
Citation APA

Retèl, V. V., Byng, D., Linn, S. S., Jóźwiak, K., Koffijberg, H., Rutgers, E. T., Cardoso, F., Piccart-Gebhart, M., Poncet, C., Van't Veer, L., & Van Harten, W. (2020). Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial. European journal of cancer, 137, 193-203. doi:10.1016/j.ejca.2020.07.002


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/312487

Retèl, V. V., Byng, D., Linn, S. S., Jóźwiak, K., Koffijberg, H., Rutgers, E. T., Cardoso, F., Piccart-Gebhart, M., Poncet, C., Van't Veer, L., & Van Harten, W. (2020). Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial. European journal of cancer, 137, 193-203. doi:10.1016/j.ejca.2020.07.002